Fig 3.
(A) Overall survival (OS) and (B) event-free survival (EFS) for patients with acute myeloid leukemia in first complete remission per conditioning regimen (fludarabine and melphalan [Flu/Mel] v busulfan and cyclophosphamide [Bu/Cy]).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.